Cme Group Inc. · NASDAQ:CME

Cme — Q1 2023 Earnings Presentation

8 slides from Cme's earnings presentation, Apr 26, 2023

  1. Slide 1: 1Q 2023 Summary

    1Q 2023 Earnings Commentary Revenue Adjusted Expense* Adjusted Diluted EPS 1Q 2023 Summary in millions CME Group’s strong performance in 1Q is evidence of the importance $1,600 $2.50 of risk management during this time of persistent uncertainty • Delivered 7% revenue growth and 15% earnings growth v

  2. Slide 2: 1Q 2023 Highlights & Commentary

    1Q 2023 Earnings Commentary - Unaudited 1Q 2023 Highlights & Commentary (ADV and open interest (OI) stated in contracts, except for cash markets) 1Q 2023 Includes Revenue Mix EBS (~$36M) CME Group’s highly diverse product set positions the company well for varying macroeconomic backdrops FX Includes

  3. Slide 3: Interest Rates and Options were standouts in 1Q23, with FX and Metals up

    1Q 2023 Earnings Commentary - Unaudited Interest Rates and Options were standouts in 1Q23, with FX and Metals activity also up from 1Q 2022 Record Interest Rates ADV of 14.5 million Equity Index ADV of 7.3 million Interest Rates ADV • Although down from the 2022 full-year record ADV of in millions 7

  4. Slide 4: Options were particularly strong with record quarterly ADV of 5.8 million contracts

    1Q 2023 Earnings Commentary - Unaudited Options were particularly strong with record quarterly ADV of 5.8 million contracts and 26% growth Options ADV Weekly Options ADV in millions in millions 6 5.8 1.5 1.4 30% 25% 4 1.0 20% 15% 2 0.5 10% 5% 0 - 0% Commodities Options ADV Financials Options ADV Wee

  5. Slide 5: 1Q 2023 Product Detail - Financials and Commodities

    1Q 2023 Earnings Commentary - Unaudited Launched 30 new products in 1Q23 including more micro offerings and weekly option expiries, and continue to support existing and new products with targeted campaign selling A few examples include: • Micro E-mini S&P MidCap 400 and SmallCap 600 futures, Micro P

  6. Slide 6: Financial Results

    1Q 2023 Earnings Commentary - Unaudited Financial Results • 1Q23 revenue was over $1.4 billion – the second- Dividends Declared $ in millions highest on record. 1Q23 clearing and transaction $2,800 fees revenue totaled $1.2 billion including approximately $75 million of transaction revenue Annual Va

  7. Slide 7: Financial Results Appendix: Micro Product Quarterly Details

    1Q 2023 Earnings Commentary - Unaudited Financial Results Appendix Micro Product Quarterly Details ADV in thousands / RPC in cents except for Micro Crypto Micro Equity Index Products (including Micro Crypto) 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 ADV 2,499 1,891 1,858 2,286 3,437 3,319 3,025 2

  8. Slide 8: Use of Non-GAAP Measures and Forward-Looking Statements

    1Q 2023 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation mate

CME Group — Q1 2023 Earnings Presentation on 6ix